Biltricide Side Effects
Generic name: praziquantel
Note: This document contains side effect information about praziquantel. Some of the dosage forms listed on this page may not apply to the brand name Biltricide.
Some side effects of Biltricide may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to praziquantel: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking praziquantel (the active ingredient contained in Biltricide) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects of praziquantel may include:
nausea, upset stomach;
mild fever; or
mild skin rash.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to praziquantel: compounding powder, oral tablet
Praziquantel (the active ingredient contained in Biltricide) is generally well tolerated. Side effects are typically mild and transient and do not require treatment. The following were observed generally in order of severity: malaise, headache, dizziness, abdominal discomfort (with or without nausea), rise in temperature and, rarely, urticaria. Such symptoms can, however, also result from the infection itself. Such side effects may be more frequent and/or serious in patients with a heavy worm burden.
The inflammatory reaction produced by antigenic substances released from dying cysts frequently involves increased intracranial pressure, seizures, severe headaches, nausea, and vomiting. In areas where Taenia solium is endemic, these reactions may occur as the result of undiagnosed cysticercosis in patients being treated for other parasitic infections. Corticosteroids are helpful in controlling this reaction, and the dosage needs to be tailored to the patient's individual needs. Corticosteroids may need to be continued past praziquantel (the active ingredient contained in Biltricide) therapy, as the duration of the reaction differs among patients. Delayed reactions have been reported.
Nervous system side effects have included headache, dizziness, and drowsiness. The treatment of neurocysticercosis with praziquantel may precipitate a cerebral inflammatory reaction in response to antigenic substances produced by dying cysts. Convulsion, somnolence, and vertigo have been reported during postmarketing experience.
Gastrointestinal side effects have included abdominal discomfort (with or without nausea), nausea and diarrhea. A syndrome of severe abdominal pain and bloody diarrhea was reported less frequently during the treatment of schistosomiasis. Gagging and vomiting have been reported due to the bitter taste of the tablets. Abdominal pain, anorexia, bloody diarrhea, and vomiting have been reported during postmarketing experience.
Other side effects have included malaise, rise in temperature, transient edema, and fever. Asthenia has been reported during postmarketing experience.
Musculoskeletal side effects have included musculoskeletal aches and fatigue. Myalgia has been reported during postmarketing experience.
Dermatologic side effects have included urticaria. At least one case of Mazzotti-like reaction has been reported. Pruritus has been reported during postmarketing experience.
A 13-year-old male developed Mazzotti reaction after treatment with ivermectin, praziquantel, and albendazole for presumptive schistosomiasis and strongyloidiasis. Six days after receiving standard empiric therapy, he developed epigastric pain, vomiting, and urticaria. This progressed in 4 hours and included fever, general myalgia and edema of the face, lower extremities and penis accompanied by urticaria of the arms, legs, and trunk. He was diagnosed with a Mazzotti reaction and treated with methylprednisolone and the symptoms subsided within 12 hours.
Hepatic side effects have included minimal increases in liver enzymes.
Cardiovascular side effects have included arrhythmia (including bradycardia, ectopic rhythms, ventricular fibrillation, atrioventricular blocks) during postmarketing experience.
Hematologic side effects have included eosinophilia during postmarketing experience.
Hypersensitivity side effects have included allergic reaction (generalized hypersensitivity) including polyserositis during postmarketing experience.
More Biltricide resources
- Biltricide Prescribing Information (FDA)
- Biltricide Concise Consumer Information (Cerner Multum)
- Biltricide Monograph (AHFS DI)
- Biltricide MedFacts Consumer Leaflet (Wolters Kluwer)
- Biltricide Advanced Consumer (Micromedex) - Includes Dosage Information
- Praziquantel Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.